x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DMM-001067
| Status | Age | Sex |
|---|---|---|
|
|
|
| Product Overview | |
|---|---|
| Model Description | Exon 2 of Slc4a7 gene was deleted to generate Slc4a7 knockout mice. |
| Strain Name | C57BL/6J-Slc4a7em1 |
| Background Strain | C57BL/6J |
| SPF | Yes |
| Research Application | Therapeutic antibody target. |
| Target Information | |
|---|---|
| Target Name | Slc4a7 |
| Synonyms | NBC3, NBCn1, NBCn1-G, E430014N10Rik, Tg(Thy1-SNCA)12Mjff |
| Gene ID | 218756 |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
